Filing Details
- Accession Number:
- 0001209191-24-003010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-08 19:40:13
- Reporting Period:
- 2024-02-08
- Accepted Time:
- 2024-02-08 19:40:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1607678 | Viking Therapeutics Inc. | VKTX | Pharmaceutical Preparations (2834) | 461073877 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614578 | Brian Lian | C/O Viking Therapeutics, Inc. 9920 Pacific Heights Blvd, Suite 350 San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2024-02-08 | 49,079 | $1.23 | 2,313,961 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2024-02-08 | 49,079 | $25.75 | 2,264,882 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Acquisiton | 2024-02-08 | 140,000 | $4.65 | 2,404,882 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2024-02-08 | 60,000 | $25.95 | 2,344,882 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2024-02-08 | 80,000 | $26.95 | 2,264,882 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2024-02-08 | 40,000 | $27.45 | 2,224,882 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.00001 Per Share | Disposition | 2024-02-08 | 40,000 | $28.90 | 2,184,882 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-02-08 | 14,148 | $0.00 | 14,148 | $1.23 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-02-08 | 34,931 | $0.00 | 34,931 | $1.23 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-02-08 | 140,000 | $0.00 | 140,000 | $4.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-01-05 | 2027-01-05 | No | 4 | M | Direct |
| 0 | 2017-01-05 | 2027-01-05 | No | 4 | M | Direct |
| 0 | 2019-01-19 | 2028-01-19 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023.
- 25% of the shares subject to the option vested on each one year anniversary of the grant date.
Billionaire Hedge Funds
